Dr. Dante Michael Sorrentino, MD

Dr. Sorrentino practices at Clay Eye Physicians and Surgeons PA/Fleming Island Optical in Orange Park, Florida.

Dr. Sorrentino's NPI, 1922418904, was assigned on April 30, 2014. Dr. Sorrentino graduated from FIU Herbert Wertheim College of Medicine in 2014. Dr. Sorrentino's California license number on file is 155316.

Dr. Sorrentino's primary practice is Clay Eye Physicians and Surgeons PA/Fleming Island Optical, at 2023 Professional Center Dr, Orange Park, FL 32073 in Clay County. The practice phone is (904) 272-2020.

Dr. Sorrentino's primary practice is Clay Eye Physicians and Surgeons PA/Fleming Island Optical in Orange Park, Florida. Dmand AI also links Dr. Sorrentino to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sorrentino practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Sorrentino's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Sorrentino is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Sorrentino's licenses on file in 4 states: California, Florida, New Mexico and Pennsylvania.

Dmand AI lists dry eye among the conditions Dr. Sorrentino treats.

CMS data shows 1,348 Medicare services from Dr. Sorrentino across 15 procedure codes in 2024, for 380 Medicare patients. Medicare paid $82,215 for them.

CMS counts 380 Medicare patients who saw Dr. Sorrentino in 2024. The largest group is 65 to 74, with 173 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sorrentino's median patient age at 72, with 60% women.

In 2024, Dr. Sorrentino wrote 799 Medicare Part D claims for 389 patients. 76% of them were for generic drugs. CMS names the drug for 687 of them, across 16 drugs with 11 or more claims each, at $43,459 in total drug cost. In 2023, CMS named 1,274 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Sorrentino for performance year 2024, reported as part of a group. Dr. Sorrentino accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 325 procedures of cataract surgery by Dr. Sorrentino, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Sorrentino in 2017. 2017 was the busiest year, with 2. The most frequent topics are Tomography, X-Ray Computed. Dr. Sorrentino's most frequent co-authors are Lance M. Bodily, MD, Jenny Y. Yu and Kenneth John Taubenslag, MD.

CMS Open Payments shows 64 general payments to Dr. Sorrentino from 18 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Bausch & Lomb Americas Inc. paid the most, $456.

Dr. Sorrentino graduated from FIU Herbert Wertheim College of Medicine in 2014. Dr. Sorrentino is a member of AOA, AAO, ASCRS, Clay County Medical Society, Duval County Medical Society and Florida Society of Ophthalmology.

Dr. Sorrentino is in network with 10 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.